Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

317 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Self-monitoring versus standard monitoring of oral anticoagulation.
Ferretti G, Giannarelli D, Carlini P, Felici A, Ciccarese M, Mandalà M, Cognetti F. Ferretti G, et al. Among authors: felici a. Thromb Res. 2007;119(3):389-90. doi: 10.1016/j.thromres.2006.08.007. Epub 2006 Oct 4. Thromb Res. 2007. PMID: 17023029 Review. No abstract available.
Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
Ferretti G, Bria E, Giannarelli D, Carlini P, Felici A, Mandala M, Papaldo P, Nistico C, Fabi A, Cuppone F, Gelibter A, Terzoli E, Cognetti F. Ferretti G, et al. Among authors: felici a. J Clin Oncol. 2005 Oct 1;23(28):7248-50; author reply 7250. doi: 10.1200/JCO.2005.01.7897. J Clin Oncol. 2005. PMID: 16192623 No abstract available.
Chemotherapy-induced amenorrhea in early breast cancer.
Ferretti G, Carlini P, Bria E, Felici A, Giannarelli D, Ciccarese M, Papaldo P, Fabi A, Cognetti F. Ferretti G, et al. Among authors: felici a. Ann Oncol. 2006 Feb;17(2):352. doi: 10.1093/annonc/mdj011. Epub 2005 Sep 12. Ann Oncol. 2006. PMID: 16157623 Free article. No abstract available.
Does low-molecular-weight heparin influence cancer-related mortality?
Ferretti G, Bria E, Giannarelli D, Carlini P, Felici A, Mandalà M, Papaldo P, Fabi A, Ciccarese M, Cognetti F. Ferretti G, et al. Among authors: felici a. Ann Oncol. 2006 Oct;17(10):1604-6. doi: 10.1093/annonc/mdl092. Epub 2006 May 2. Ann Oncol. 2006. PMID: 16670203 Free article. No abstract available.
Darbepoetin alfa and history of thromboembolic events.
Ferretti G, Felici A, Cognetti F. Ferretti G, et al. Among authors: felici a. J Clin Oncol. 2009 Nov 20;27(33):e211; author reply e212. doi: 10.1200/JCO.2009.24.6454. Epub 2009 Oct 26. J Clin Oncol. 2009. PMID: 19858373 No abstract available.
Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials.
Ferretti G, Bria E, Giannarelli D, Felici A, Papaldo P, Fabi A, Di Cosimo S, Ruggeri EM, Milella M, Ciccarese M, Cecere FL, Gelibter A, Nuzzo C, Cognetti F, Terzoli E, Carlini P. Ferretti G, et al. Among authors: felici a. Br J Cancer. 2006 Jun 19;94(12):1789-96. doi: 10.1038/sj.bjc.6603194. Epub 2006 May 30. Br J Cancer. 2006. PMID: 16736002 Free PMC article.
317 results